Traws Pharma, Inc. - Common Stock TRAW 深 滬
等待開盤 08-22 09:30:00 美东时间
1.38
+0.050
+3.76%
華盛通- 最 高1.42
- 今 開1.34
- 成交量 5.95万股
- 最 低 1.3274
- 昨 收 1.33
- 總市值 974.80万
- 52周最高 19.44
- 市盈率 靜 --
- 換手率 0.84%
- 52周最低 0.97
- 委 比 71.47%
- 總股本 706.38万
- 歷史最高 1751062.50
- 量 比 0.15
- 振 幅 6.96%
- 歷史最低 0.97
- 每 手 1
- 風險率 4.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Traws Pharma Receives HREC Approval To Initiate Phase 2 COVID Studies Of Ratutrelvir, A Ritonavir-Free Treatment, With Results Expected By Year-End 2025
Non-inferiority trial to assess safety and efficacy, including rates of disease rebound and incidence of Long COVID development of ratutrelvir, a ritonavir-free treatment, compared to PAXLOVIDSeparate single-arm trial
08-18 19:08
Traws Pharma Receives Approval to Proceed with Phase 2 COVID Studies with Ratutrelvir, Expects Results by Year-End 2025
Traws Pharma announced the launch of Phase 2 trials for ratutrelvir, a ritonavir-free COVID treatment, to compare its safety and efficacy with Paxlovid. The trials will assess disease rebound rates, Long COVID incidence, and safety in Paxlovid-ineligible patients. Top-line results are expected by year-end 2025. Ratutrelvir aims to overcome shortcomings of current treatments, including unfavorable drug interactions and limited efficacy, with once-...
08-18 11:00
Traws Pharma Q2 2025 GAAP EPS $(0.11) Up From $(20.52) YoY, Sales $2.733M Up From $57.000K YoY
Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.11) per share. This is a 99.46 percent increase over losses of $(20.52) per share from the same period last year. The company reported $2.733 million in sales
08-14 19:04
Earnings Scheduled For August 14, 2025
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
Traws Pharma, a clinical-stage biopharmaceutical company focused on novel therapies for respiratory viral diseases, will host a conference call on August 14, 2025, at 8:30 AM ET to discuss Q2 2025 financial results and recent progress. The call will be accessible via telephone or webcast, with replay available later. Traws is advancing antiviral agents targeting bird flu, seasonal influenza, and COVID-19, including Tivoxavir marboxil and Ratutrel...
08-08 11:00
Traws Pharma Seeks FDA Guidance On TXM For Bird Flu; Submits Phase 2 Studies For TXM, Ratutrelvir In Flu And COVID
Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined seasonal and bird flu study in the Southern HemisphereBriefing documents submitted to FDA for a Type D meeting request to continue
06-30 18:45
Traws Pharma advances antiviral pipeline with multiple regulatory submissions
Traws Pharma (NASDAQ:TRAW) on Monday announced multiple regulatory submissions related to its antiviral pipeline. Phase 2 protocol submitted to HREC to evaluate tivoxavir marboxil (TXM) in a combined ...
06-30 18:44
Traws Pharma Advances Antiviral Pipeline with Multiple Regulatory Submissions
Traws Pharma submitted Phase 2 protocols for tivoxavir marboxil (TXM) to evaluate its efficacy against seasonal and bird flu, and for ratutrelvir to assess its effectiveness in COVID-19 patients, including those ineligible for PAXLOVID®. Briefing materials were also submitted to the FDA for a Type D meeting to explore accelerated approval for TXM for bird flu. The company aims to advance its antiviral portfolio to address critical respiratory vir...
06-30 10:30
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE:RH) rose sharply in today's pre-market trading as the compan...
06-13 17:08
Traws Pharma Publishes Key Clinical Efficacy Data For Rigosertib, Oncology Asset For Which Development And Commercialization Partners Are Being Actively Sought, In Patients With RDEB SCC
Traws Pharma, Inc. (NASDAQ:TRAW) ("Traws Pharma", "Traws" or "the Company"), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral
06-03 19:03
